J. Jeffrey Marshall

1.5k total citations
27 papers, 967 citations indexed

About

J. Jeffrey Marshall is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Jeffrey Marshall has authored 27 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Jeffrey Marshall's work include Coronary Interventions and Diagnostics (6 papers), Nitric Oxide and Endothelin Effects (4 papers) and Cardiac Imaging and Diagnostics (4 papers). J. Jeffrey Marshall is often cited by papers focused on Coronary Interventions and Diagnostics (6 papers), Nitric Oxide and Endothelin Effects (4 papers) and Cardiac Imaging and Diagnostics (4 papers). J. Jeffrey Marshall collaborates with scholars based in United States, United Kingdom and Australia. J. Jeffrey Marshall's co-authors include H. A. Kontos, E. P. Wei, William S. Weintraub, James R. Staples, Elizabeth M. Mahoney, Rebecca Petersen, Robert A. Guyton, Haitao Chu, P Huber and John D. Puskas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

J. Jeffrey Marshall

26 papers receiving 940 citations

Peers

Countries citing papers authored by J. Jeffrey Marshall

Since Specialization

Citations

This map shows the geographic impact of J. Jeffrey Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Jeffrey Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Jeffrey Marshall more than expected).

Fields of papers citing papers by J. Jeffrey Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Jeffrey Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Jeffrey Marshall. The network helps show where J. Jeffrey Marshall may publish in the future.

Co-authorship network of co-authors of J. Jeffrey Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of J. Jeffrey Marshall. A scholar is included among the top collaborators of J. Jeffrey Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Jeffrey Marshall. J. Jeffrey Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preferences between three options for androgen deprivation therapy: a focus group study 2025 ·British Journal of Urology ·Hannah Rush, (unknown), J. Jeffrey Marshall, (unknown), Hassan Abdel‐Aty, Abdulla Alhasso, Noel W. Clarke, Roger Kockelbergh, Stephen Mangar, Stuart D. Rosen, Nicholas D. James, Duncan C. Gilbert, Annabelle South, Ruth E. Langley	0
2	Regional anaesthesia research priorities: a Regional Anaesthesia UK ( RA ‐ UK ) priority setting partnership involving patients, carers and healthcare professionals 2024 ·Anaesthesia ·(unknown), James F. Lloyd, (unknown), Alan Macfarlane, Jonathan Womack, Kariem El‐Boghdadly, Cliff Shelton, (unknown), Tom Quick, Andrew F Smith, (unknown), Annabel Pearson, (unknown), Daniel Rodger, J. Jeffrey Marshall, Carol Pellowe, James Bowness, Rachel Kearns	2
3	LBA69 Prostate cancer efficacy results from a randomised phase III evaluation of transdermal oestradiol (tE2) versus luteinising hormone releasing hormone agonists (LHRHa) for androgen suppression in non-metastatic (M0) prostate cancer 2024 ·Annals of Oncology ·(unknown), (unknown), Duncan C. Gilbert, (unknown), Stephen Mangar, Hannah Rush, Stuart D. Rosen, Abdulla Alhasso, Roger Kockelbergh, J. Jeffrey Marshall, Anne M. Griffiths, (unknown), (unknown), (unknown), Sarah Brown, Nigel Clarke, Nicholas D. James, (unknown)	2
4	Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial 2023 ·SHILAP Revista de lepidopterología ·(unknown), Emma Clark, (unknown), (unknown), Holly Fisher, (unknown), Ruth Wood, Helen Hancock, (unknown), (unknown), Rebecca Maier, J. Jeffrey Marshall, Robert W. Chandler, Amit Bahl, Simon J. Crabb, Suneil Jain, Ian Pedley, Robert J. Jones, John Staffurth, Rakesh Heer	4
5	PCI has no role in patients with heart failure and reduced ejection fraction: pros and cons 2023 ·EuroIntervention ·Divaka Perera, J. Jeffrey Marshall, Cindy L. Grines	1
6	Use of Artificial Intelligence on Retinal Images to Accurately Predict the Risk of Cardiovascular Event (CVD-AI) 2022 ·SSRN Electronic Journal ·Ehsan Vaghefi, David Squirrell, Song Yang, (unknown), J. Jeffrey Marshall	1
7	Obesity and low levels of physical activity impact on cardiopulmonary fitness in older men after treatment for prostate cancer 2021 ·European Journal of Cancer Care ·Sara Faithfull, Agnieszka Lemańska, Karen Poole, Jonathan Aning, Ralph Manders, J. Jeffrey Marshall, John Saxton, (unknown), Bruce A. Griffin	3
8	Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment 2021 ·Supportive Care in Cancer ·Agnieszka Lemańska, Karen Poole, Ralph Manders, J. Jeffrey Marshall, Zachariah Nazar, (unknown), John Saxton, (unknown), Gary Warner, Bruce A. Griffin, Sara Faithfull	12
9	Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol 2019 ·BMJ Open ·Emma Clark, (unknown), (unknown), Holly Fisher, Denise Howel, (unknown), Ruth Wood, Helen Hancock, Rebecca Maier, J. Jeffrey Marshall, Amit Bahl, Simon J. Crabb, Suneil Jain, Ian Pedley, Robert J. Jones, John Staffurth, Rakesh Heer	6
10	Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49) 2019 ·The American Journal of Cardiology ·C. Michael Gibson, Varun Kumar, Lakshmi Gopalakrishnan, (unknown), (unknown), Samer Kazziha, Chandan Devireddy, Duane S. Pinto, J. Jeffrey Marshall, George A. Stouffer, Kreton Mavromatis, Laura T. Grip, Kevin R. Bainey	19
11	Reimbursement for coronary intervention 2013 ·Catheterization and Cardiovascular Interventions ·James C. Blankenship, J. Jeffrey Marshall	4
12	Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: A prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting 2003 ·Journal of Thoracic and Cardiovascular Surgery ·John D. Puskas, Willis H. Williams, Peggy G. Duke, James R. Staples, (unknown), J. Jeffrey Marshall, (unknown), P Huber, (unknown), (unknown), (unknown), Rebecca Petersen, (unknown), Haitao Chu, Elizabeth M. Mahoney, William S. Weintraub, Robert A. Guyton	438
13	Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era 2003 ·American Heart Journal ·Ziyad M.B. Ghazzal, Salman Ashfaq, Douglas C. Morris, John S. Douglas, J. Jeffrey Marshall, Spencer B. King, William S. Weintraub	30
14	Acute renal artery thrombosis treated by percutaneous rheolytic thrombectomy 2002 ·Catheterization and Cardiovascular Interventions ·(unknown), (unknown), J. Jeffrey Marshall	23
15	Tranilast inhibits neointima formation in balloon-injured and stented pig coronary arteries, and decreases negative remodeling after balloon injury 1998 ·Journal of the American College of Cardiology ·Sugao Ishiwata, N. Chronos, (unknown), J. Jeffrey Marshall, Spencer B. King, Keith A. Robinson	22
16	930-105 Xanthine-Oxidase Inhibition Improves Coronary Endothelium-Mediated Relaxation in Patients with Early Atherosclerosis 1995 ·Journal of the American College of Cardiology ·(unknown), David G. Harrison, J. Larry Klein, William Anderson, J. Jeffrey Marshall, Jian Zhang, R. Wayne Alexander, Charles B. Treasure	1
17	Subclavian artery dissection during diagnostic cardiac catheterization: The role of conservative management 1995 ·Catheterization and Cardiovascular Diagnosis ·Stephen Frohwein, (unknown), J. Jeffrey Marshall	13
18	Subclavian balloon angioplasty in the management of the coronary‐subclavian steal syndrome 1992 ·Catheterization and Cardiovascular Diagnosis ·Michael Belz, J. Jeffrey Marshall, (unknown), George W. Vetrovec	18
19	In vivo bioassay of endothelium-derived relaxing factor 1988 ·American Journal of Physiology-Heart and Circulatory Physiology ·H. A. Kontos, E. P. Wei, J. Jeffrey Marshall	49
20	Structured postoperative teaching and knowledge and compliance of patients who had coronary artery bypass surgery. 1986 ·PubMed ·J. Jeffrey Marshall, Sue Penckofer, (unknown)	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact